Bad News

Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line interference of Metastatic Colorectal Cancer info from randomize clinical visitations have shown that cetuximab is active in metastatic colorectal cancer (mCRC). Promising results have been reported from point II studies that evaluated the safety and efficacy of cetuximab combined with oxaliplatin, leucovorin, and fluorouracil (FOLFOX-4) in patients with mCRC. Therefore, investigators for the Oxaliplatin and Cetuximab in First-Line Treatment of mCRC (OPUS) field of force now report the results of an open-label, randomized, frame II study that compared the efficacy and safety of cetuximab cocksure FOLFOX-4 against FOLFOX-4 altogether as main(a) give-and-take for mCRC. In addition, a subgroup analysis was performed base on KRAS gene mutational status to determine its prophetical take to be for the cetuximab confident(p) FOLFOX-4 regimen. The results showed that cetuximab plus FOLFOX -4 improved boilers suit response place (ORRs) when compared with FOLFOX-4 alone in patients with tumors conferring wild-type KRAS status. The OPUS trial involved 337 patients with antecedently untreated, nonresectable, epidermal growth factor receptor?positive mCRC. Patients from 79 centers were enrolled from July 2005 to March 2006.

The patients were randomly assigned to the cetuximab plus FOLFOX-4 group (n = 169) or to the FOLFOX-4 alone group (n = 168). Cetuximab was given on day 1 as a 2-hour infusion (400 mg/m2), followed by each week 1-hour infusions (250 mg/m2). The FOLFOX-4 regimen consisted of oxaliplatin (85 mg/m2 on day 1), leucovorin (200 mg/m2), and 5-fluorouracil (400 mg /m2 bolus followed by 600 mg/m2 infusion dur! ing 22 hours on days 1 and 2). The 2-week treatment cycles were repeated until disease development or unacceptable toxicity occurred. The primary endpoint was the ORR for cetuximab plus FOLFOX-4 vs FOLFOX-4 alone. KRAS mutational status was assessed in tumors of 233 patients by polymerase chain chemical reaction (cetuximab plus FOLFOX-4...If you compulsion to get a full essay, severalize it on our website: OrderEssay.net

If you want to get a full information about our service, visit our page: write my essay